Home  |  Contact

UniProtKB/Swiss-Prot P46059: Variant p.Thr451Asn

Solute carrier family 15 member 1
Gene: SLC15A1
Variant information

Variant position:  451
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Threonine (T) to Asparagine (N) at position 451 (T451N, p.Thr451Asn).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and polar.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  451
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  708
The length of the canonical sequence.

Location on the sequence:   DVNKLTRINISSPGSPVTAV  T DDFKQGQRHTLLVWAPNHYQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DVNKLTRINISSPGSP-VTAVTDDFKQGQRHTLLVWAPNHYQ

                              DVDKLTSINISSTGSP-VIPVTYNFEQGHRHTLLVWAPNNY

Mouse                         DIDKLTSINISSSGSPGVTTVAHDFEQGHRHTLLVWNPSQY

Rat                           DVDQLTSINVSSPGSPGVTTVAHEFEPGHRHTLLVWGPNLY

Rabbit                        NEDTLTSINITS-GSQ-VTMITPSLEAGQRHTLLVWAPNNY

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 708 Solute carrier family 15 member 1
Topological domain 383 – 584 Extracellular
Region 383 – 584 Extracellular domain (ECD)
Glycosylation 439 – 439 N-linked (GlcNAc...) asparagine


Literature citations

Genetic variants of the human dipeptide transporter PEPT1.
Anderle P.; Nielsen C.U.; Pinsonneault J.; Krog P.L.; Brodin B.; Sadee W.;
J. Pharmacol. Exp. Ther. 316:636-646(2006)
Cited for: VARIANTS ILE-21; TYR-28; ASN-117; ARG-117; MET-122; ALA-419; ILE-450; ASN-451 AND SER-537;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.